[artículo] 
inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.3 (Marzo) . - pp. 356-364

Título :	Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin–dopamine activity modulator
Tipo de documento:	texto impreso
Autores:	Noriko Yoshimi, Autor ; Takashi Futamura, Autor ; Kenji Hashimoto, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 356-364
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Fármaco antipsicótico, Brexpiprazol, Dizocilpina, Reconocimiento social, Receptor 5-HT1A
Resumen:	Cognitive impairment, including impaired social cognition, is largely responsible for the deterioration in social life suffered by patients with psychiatric disorders, such as schizophrenia and major depressive disorder (MDD).
Link:	./index.php?lvl=notice_display&id=26816

[artículo] Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin–dopamine activity modulator [texto impreso] / Noriko Yoshimi, Autor ; Takashi Futamura, Autor ; Kenji Hashimoto, Autor . - 2021 . - pp. 356-364.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.3 (Marzo) . - pp. 356-364

Palabras clave:	Fármaco antipsicótico, Brexpiprazol, Dizocilpina, Reconocimiento social, Receptor 5-HT1A
Resumen:	Cognitive impairment, including impaired social cognition, is largely responsible for the deterioration in social life suffered by patients with psychiatric disorders, such as schizophrenia and major depressive disorder (MDD).
Link:	./index.php?lvl=notice_display&id=26816